First startup blooms from Mayo Clinic cell and gene therapy accelerator with $750M Cellectis partnership

First startup blooms from Mayo Clinic cell and gene therapy accelerator with $750M Cellectis partnership

Source: 
Fierce Biotech
snippet: 

Seeds from Mayo Clinic’s cell and gene therapy accelerator Mayflower Bioventures have taken flight in a new biotech called Primera Therapeutics, which launches today with a blossoming $750 million partnership to work on therapies for mitochondrial diseases.